COMPARISION OF ACID-SUPPRESSION AND SAFETY BETWEEN TEGOPRAZAN 50 MG AND REVAPRAZAN 200 MG IN HEALTHY MALE SUBJECTS.
CLINICAL PHARMACOLOGY & THERAPEUTICS(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL PHARMACOLOGY & THERAPEUTICS(2019)